Benjamin Auer to Radiopharmaceuticals
This is a "connection" page, showing publications Benjamin Auer has written about Radiopharmaceuticals.
Connection Strength
0.248
-
Dorbala S, Maurer MS, Cuddy SAM, Auer BD, Kijewski MF, Clerc OF, Khouri MG, Mitchell JD, Sperry BW, Hanna M, AbouEzzeddine OF, Malhotra S, Wall JS, Guthrie S, Di Carli MF, Ruberg FL, Dilsizian V, Dispenzieri A, Udelson JE, Narra RK, Masri AM. Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis. J Nucl Cardiol. 2026 Jul; 61:102773.
Score: 0.057
-
Miller RJ, Clerc OF, Cuddy SA, Auer B, Kijewski MF, Miller EJ, Slomka PJ, Dorbala S. Quantitative cardiac amyloid radionuclide imaging. J Nucl Cardiol. 2026 May; 59S:102724.
Score: 0.057
-
Vijayakumar S, Pabon AR, Clerc OF, Cuddy SAM, Gu Y, Watts C, Sullivan K, Auer B, Kijewski MF, DiCarli MF, Falk RH, Dorbala S. Quantitative 99mTc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy. J Nucl Cardiol. 2024 Sep; 39:102019.
Score: 0.050
-
Walker SM, Schneider A, Olulade O, Zabel T, Wakefield C, Auer B, Barletta JA, Marqusee E, Shah H. Illustrative Review of Nuclear Medicine Thyroid Studies. Radiographics. 2024 02; 44(2):e230095.
Score: 0.048
-
K?nik A, Auer B, De Beenhouwer J, Kalluri K, Zeraatkar N, Furenlid LR, King MA. Primary, scatter, and penetration characterizations of parallel-hole and pinhole collimators for I-123 SPECT. Phys Med Biol. 2019 12 13; 64(24):245001.
Score: 0.036